Responding to research into the impact a Mediterranean diet, with added olive oil, may have on breast cancer risk (published today in Jama...

14 September 2015

We are bitterly disappointed to learn that Kadcyla and Avastin will, from November, no longer be made available through the fund on the basis of cost...

4 September 2015

Responding to the decision to remove two breast cancer drugs, trastuzumab emtansine (Kadcyla) and bevacizumab (Avastin), from the Cancer Drugs Fund,...

4 September 2015

Responding to initial results from research into being able to use a blood test to predict which patients are likely to have a breast cancer...

26 August 2015

A US study of over 100,000 women diagnosed with DCIS between 1988 to 2011 has shown that while their overall risk of dying from breast cancer was low...

25 August 2015

The study also found fertility concerns led a quarter of women who started tamoxifen to stop taking it before the recommended treatment period ended...

25 August 2015

Responding to a study published in the Journal of the National Cancer Institute, which showed that concerns about fertility kept some younger women...

24 August 2015

Responding to a new US study, published in the British Medical Journal, that suggests even light to moderate drinking among women was associated with...

18 August 2015

Responding to the latest NHS Cancer Waiting Time Target monthly figures for June 2015 released today, Danni Manzi, Head of Policy and Campaigns at...

13 August 2015